A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma
Clinical trial NCT00531453 · COMPLETED
Trial details
- NCT number
- NCT00531453
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2009-04-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.